000 01622 a2200457 4500
005 20250515131208.0
264 0 _c20080828
008 200808s 0 0 eng d
022 _a0001-5385
024 7 _a10.2143/AC.63.3.1020313
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhao, Jing-Lin
245 0 0 _aIntravenous adenosine reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel.
_h[electronic resource]
260 _bActa cardiologica
_cJun 2008
300 _a355-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aCoronary Circulation
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aEchocardiography
650 0 4 _aEndothelin-1
_xblood
650 0 4 _aInjections, Intravenous
650 0 4 _aKATP Channels
_xdrug effects
650 0 4 _aMyocardial Infarction
_xdiagnosis
650 0 4 _aMyocardial Reperfusion Injury
_xdiagnosis
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aRadioimmunoassay
650 0 4 _aRandom Allocation
650 0 4 _aSwine
650 0 4 _aSwine, Miniature
650 0 4 _aTreatment Outcome
650 0 4 _aVasodilator Agents
_xadministration & dosage
700 1 _aYang, Yue-Jin
700 1 _aPei, Wei-Dong
700 1 _aSun, Yu-Hua
700 1 _aChen, Ji-Lin
700 1 _aGo, Run-Lin
773 0 _tActa cardiologica
_gvol. 63
_gno. 3
_gp. 355-9
856 4 0 _uhttps://doi.org/10.2143/AC.63.3.1020313
_zAvailable from publisher's website
999 _c18140822
_d18140822